Human mesenchymal stem cell (hmsc) donor potency selection for the “first in cystic fibrosis” phase i clinical trial (cease-cf)
HIGHLIGHTS who: Tracey L. Bonfield and collaborators from the Department of Genetics and Genome Sciences, National Center Regenerative Medicine and […]